MarketWatch (press release) The global pain management therapeutics market is expected to witness a decline during the forecast period (2012 to 2018) due to patent expirations of the key blockbuster revenue generating drugs such as Cymbalta ( duloxetine ) of Eli Lilly & Co. and ... and more »
MarketWatch (press release) The global pain management therapeutics market is expected to witness a decline during the forecast period (2012 to 2018) due to patent expirations of the key blockbuster revenue generating drugs such as Cymbalta ( duloxetine ) of Eli Lilly & Co. and ... and more »
